ADPT - CIK 0001478320
Adaptive Biotechnologies Corp (ADPT) reported net income of -$59.50M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$59.50M | +62.7% |
| FY 2024 | -$159.49M | +29.2% |
| FY 2023 | -$225.25M | -12.5% |
| FY 2022 | -$200.19M | +3.4% |
| FY 2021 | -$207.28M | -41.8% |
| FY 2020 | -$146.23M | -113.1% |
| FY 2019 | -$68.61M | -47.7% |
| FY 2018 | -$46.45M | -8.4% |
| FY 2017 |
Adaptive Biotechnologies Corp (ADPT) reported net income of -$59.50M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2017 and fiscal 2025, Adaptive Biotechnologies Corp's net income declined from -$42.83M to -$59.50M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$42.83M |
| - |